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The sequence of the complete genome of ovine enzootic nasal tumor virus, an exogenous retrovirus associ-
ated exclusively with contagious intranasal tumors of sheep, was determined. The genome is 7,434 nucleotides
long and exhibits a genetic organization characteristic of type B and D oncoviruses. Enzootic nasal tumor virus
is closely related to the Jaagsiekte sheep retrovirus and to sheep endogenous retroviruses.
Animal models of retrovirus-induced tumors of the lym-
phoreticular system are numerous and have contributed
greatly to our understanding of oncogenesis (reviewed in ref-
erence 10). However, animal models of retrovirus-associated
epithelial tumors are restricted to mouse mammary tumors,
sheep pulmonary adenomatosis (SPA), and enzootic nasal tu-
mors (ENT) of sheep and goats. Of these, ENT and SPA are
also important for economic and animal welfare considerations
in affected flocks. Both have long incubation periods, but once
clinical signs become apparent the diseases are invariably fatal.
There is compelling evidence that SPA (also known as Jaag-
siekte or ovine pulmonary carcinoma) is caused by Jaagsiekte
sheep retrovirus (JSRV) (reviewed in reference (15), although
classical approaches to investigate the presence of an etiolog-
ical role for this virus continue to be hampered by the lack of
a cell culture system to propagate JSRV. The relationship
between ENT and its associated retrovirus, enzootic nasal tu-
mor virus (ENTV), is less well characterized. The presence of
the retrovirus was first shown by electron microscopy in intra-
nasal tumors of sheep (7, 23, 37) and goats (4, 5, 35) and in
nasal fluid produced by these tumors. Antigenic cross-reactiv-
ity of ENTV with Mason-Pfizer monkey virus (MPMV) p27 (6,
31) and recombinant JSRV capsid protein (7) indicated that
ENTV has a type D retroviral capsid. However, although the
complete genome of JSRV has been sequenced (38), the data
for ENTV is limited to two small regions of the gag gene (3,
29). The close homology between JSRV and sheep endoge-
nous retroviral sequences (SERVs) (14, 38) was a problem for
the development of JSRV-specific PCRs. This was finally re-
solved by the identification of small areas of sequence differ-
ence between JSRV and SERVs (1, 26). A similar approach is
required to develop sensitive ENTV-specific detection tech-
niques in order to elucidate the role of ENTV in disease. This
is particularly important because ENTV, like JSRV, does not
replicate in tissue culture.
Here we report the cloning and sequencing of the complete
ENTV genome from an ovine case of ENT and investigate its
relationship to JSRV, SERVs, and other retroviruses. This
data is a vital step in the study of this animal model of epithe-
lial cell-derived tumors and opens the way to further studies to
elucidate the pathogenesis and oncogenic mechanisms of this
virus.
MATERIALS AND METHODS
Source of material. Nasal fluid from a sheep with naturally occurring ENT was
collected, clarified, and concentrated as described previously (6). The resultant
pellet was resuspended as a 100-fold concentrate in TNE buffer (0.01 M Tris-Cl
[pH 7.5], 0.1 M NaCl, 0.001 M EDTA). Samples of ENT and kidney were
collected from this sheep at necropsy and snap frozen in liquid nitrogen. Tissue
samples were stored at 270°C. DNA was extracted from these tissues by the
method of Wu et al. (36). The sheep was verified to be negative for SPA by
macroscopic and microscopic pathologic testing at necropsy.
Density gradient fractionation. ENTV was purified from 200 ml of 100-fold-
concentrated nasal fluid by isopycnic centrifugation on 20 to 55% (wt/wt) sucrose
gradients (16). Fractions (0.5 ml) were collected, and fractions with densities
between 1.17 and 1.19 g/ml were pooled, diluted in TNE buffer and centrifuged
at 100,000 3 g for 1 h at 4°C. The pellet was resuspended in 0.5 ml of solution
D (4 M guanidinium thiocyanate, 25 mM sodium citrate [pH 7.0], 0.5% [wt/vol]
sarcosyl, 0.1 M 2-mercaptoethanol) for RNA preparation.
RNA preparation and reverse transcription. Total RNA was extracted from
pooled sucrose gradient fractions by the acid guanidinium thiocyanate-phenol-
chloroform method (2), without adding carrier RNA or treating with DNase. The
RNA was resuspended in 15 ml of 1 mM EDTA. cDNA was synthesized by
random-primed or oligo(dT)-primed reverse transcription with the Moloney
murine leukemia virus (H-) riboclone cDNA synthesis system (Promega). The
presence of ENTV cDNA was confirmed by gag-PCR (3).
Construction of cDNA libraries. EcoRI linkers were ligated to the cDNA by
using the Riboclone EcoRI adapter ligation system (Promega). Excess adapters
were removed from the ligation product with Sephacryl-400 as directed by the
manufacturer. All of the cDNA-linker product was ligated to lambda arms by
using the lZapII-EcoRI-calf intestinal alkaline phosphatase cloning kit as de-
scribed by the manufacturer (Stratagene). Gigapack II Gold packaging extract
(Stratagene) was used for packaging.
Recombinant clones were selected initially with JSRV clones as probes
(pJS382 [38], pJS107 [38], and pLG1 [26]) and later by using ENTV clones from
the library. The selected clones were excised by using plating strain SOLR, which
converts lambda ZapII to Bluescript SK(2) plasmid and allows for blue-white
screening for inserts.
PCR. Gaps in the sequence were filled by PCR with primers chosen from the
available ENTV sequence data. The positions of the PCR fragments relative to
the ENTV genome are shown in Fig. 1. In each case, PCR products were pooled
from at least four independent reactions, gel purified, and cloned into pGEMT
(Promega) or pCR2.1 (Invitrogen) as specified by the manufacturers. Product a
was amplified from cDNA made from ENTV RNA prepared as described above.
Products b, c, and d were obtained by amplification of ENTV provirus from nasal
tumor DNA.
(i) PCR a. Product a was amplified from ENTV cDNA with primers ATGG
GAGCCCTACAACCTGG (nucleotides [nt] 3113 to 3131 [Fig. 2]) and CACG
AGGATACAAGGAGAAACC (reverse of nt 3542 to 3572 [Fig. 2]). The PCR
was carried out in 2.5 mM MgCl2–10 mM Tris (pH 9.2)–50 mM KCl–20 mM
(NH4)2SO4–200 mM each deoxynucleoside triphosphate (dNTP)–0.125 mM each
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primer–1.25 U of Taq. A total of 45 cycles were used, each consisting of 1 min at
94°C, 30 s at 59°C, and 1 min at 72°C.
(ii) PCR b. A 250-ng portion of nasal tumor DNA was used as template for the
first round of PCR with primers PL1 (TCAGGAAGTCTTAAGAGCTTTTAG)
(nt 7267 to 7290 [Fig. 2]), and PG1 (ATACTGCAGCYCGATGGCCAG) (re-
verse of nt 1802 to 1822 [Fig. 2]). A 2-ml volume of the product of this PCR was
used in the second round of amplification with primers PL2 (GATGTCTTTTG
GTTTTGCAACATG) (nt 7297 to 7320 [Fig. 2]) and PG1. The same conditions
were used for both the first and second rounds of PCR as follows: 1.5 mM
MgCl2–50 mM KCl–10 mM Tris-HCl (pH 8.3)–100 mM each dNTP–10 pmol of
each primer–1.25 U of Taq polymerase (Boehringer). The PCR cycles were 94°C
for 4 min, then 30 cycles at 94°C for 40 s, 63°C for 40 s, and 72°C for 90 s plus
a progressive increment at 72°C of 10 s per cycle from cycle 11 onward, and a
final extension of 72°C for 7 min. A tumor-specific product of approximately 2 kb
was confirmed to originate from ENTV by demonstration of the gag PstI site
previously shown to be a molecular marker for ENTV (reference 3 and data not
shown).
(iii) PCR c. Fragment c was amplified from nasal tumor DNA with primers
PL3 (ATGATCTCAAGTTACTTAACTTGC) (nt 4859 to 4880 [Fig. 2]) and
NT4R (CTGTTCTGGATTGGTAGTTTGG) (reverse of nt 7376 to 7399 [Fig.
2]). The PCR conditions were 100 ng of template DNA–50 mM KCl–10 mM
Tris-HCl (pH 8.3)–2 mM MgCl2–12.5 pmol of each primer–200 mM each
dNTP–1 U of Taq polymerase. A total of 40 cycles of 94°C for 1 min, 59°C for 1
min, and 72°C for 2 min were performed, with a final extension of 5 min at 72°C.
(iv) PCR d. Fragment d was amplified with PCR primers NTG4F (CTCATG
GCTTCCCTTCATACTG) and PL4 (AAGCAAGTTAAGTAACTTGAGA
TC) with nasal tumor DNA as the template. The PCR conditions were 100 ng of
template DNA–50 mM KCl–10 mM Tris-HCl (pH 8.3)–1.5 mM MgCl2–12.5
pmol of each primer–200 mM each dNTP–1 U of Taq polymerase. A total of 40
cycles of 94°C for 1 min, 52°C for 1 min, and 72°C for 2.5 min were performed,
with a final extension of 5 min at 72°C.
Sequence analysis and phylogeny. Each clone was sequenced in the forward
and reverse orientations with a Li-Cor automated sequencer. The clones were
ordered initially by alignment with JSRV by using the Genetics Computer Group
(GCG) Bestfit program (13). The sequence data were compiled with the GCG
fragment assembly package (13). The sequence of ENTV was confirmed by
sequencing at least two overlapping clones. Sequences obtained by PCR ampli-
fication were confirmed by sequencing at least three independent clones. As
would be expected for sequences of an uncloned virus population, albeit isolated
from a single animal, some differences were found. Where differences occurred,
the consensus sequence is shown.
The GCG programs Eclustalw and Clustree were used for phylogenetic anal-
ysis. Percent divergence figures between all pairs of sequences were calculated
and used to generate unrooted phylogenetic trees by the neighbor-joining
method of Saitou and Nei (30).
Nucleotide sequence accession numbers. The nucleotide sequence of the com-
plete genome of ovine ENTV will appear in the EMBL Nucleotide Sequence
Database under accession no. Y16627.
RESULTS
A total of 39 clones were selected by screening of the ENTV
cDNA libraries. Sequencing of these clones generated more
than 75% of the ENTV genome. The remaining gaps, as iden-
tified by alignment with the JSRV genome, were generated by
PCR (Fig. 1). Gap a in the pol gene was filled by PCR on
cDNA from virus purified from nasal fluid from an animal with
ENT. The sequencing gaps remaining at either end of the virus
were amplified by PCR from nasal tumor genomic DNA, tak-
ing advantage of the fact that the long terminal repeat (LTR)
is duplicated in the provirus (product b in Fig. 1). ENTV-
specific U3 primers were designed by selecting regions of dif-
ference between the clones from the library and the published
sequences of endogenous sheep retroviruses (1, 26) and used
to amplify the region from U3 across U5 into gag. The LTR
sequence obtained from these clones allowed the identification
of a unique region in the ENTV LTR, from which more effi-
cient exogenous specific PCR primers, PL3 and PL4, were
chosen. These primers, together with primers from within pro
or pol, respectively, allowed amplification from tumor DNA of
products c and d, which included the two remaining sequence
gaps. Control reactions, with kidney DNA from the same an-
imal as the template, verified that the PCRs amplified only
exogenous ENTV and not endogenous sequences. We have
previously reported the presence of two restriction enzyme
sites, PstI and AatII, within gag which are specific for ENTV
(3). These occur at bases 1691 to 1696 and 1757 to 1762,
respectively, in the full-length sequence of ENTV (Fig. 2). No
JSRV or endogenous sequences that have these specific sites
have been reported. Both these sites were present in all our
clones spanning this region, which is further evidence that
these clones were not derived from endogenous sequences.
Furthermore, none of the clones contained the JSRV-specific
ScaI site in gag (26).
The complete sequence of ovine ENTV is shown in Fig. 2.
The genome is 7,434 nt long. It has a genetic organization
typical of type B and D retroviruses in that it has gag, pro, pol,
and env genes (Fig. 3). No further open reading frames are
present in ENTV. Comparison with other retroviruses suggest
that pro and pol are expressed as gag-pro and gag-pro-pol pre-
cursors generated by ribosomal frameshifting and that env
transcripts are generated by splicing.
LTR. The LTR of ENTV is 374 bases long and is bound by
the inverted-repeat sequences GCAG (nt 122 to 125) and
CTGC (nt 7172 to 7175) and flanked by the primer binding site
(nt 127 to 142) and the polypurine tract (nt 7154 to 7170). U3
is 249 bp, R is 13 bp, and U5 is 112 bp. U3 is defined as the
region between R and the polypurine tract that contains the
initiation site for synthesis of the positive strand of viral DNA.
Like JSRV, ENTV uses tRNA1,2
Lys as the primer for reverse
transcriptase (RT) to initiate minus-strand synthesis. In the
DNA form of retroviral LTRs, the U3 region contains cis-
acting sequences necessary for viral replication and regulatory
signals for retroviral transcription. Although the ENTV LTR
must interact with cellular factors, no recognized consensus
sequences for transcription factor binding sites were identifi-
able. Experiments with expression constructs involving the
LTR linked to a reporter gene must be performed before the
functional regions of the ENTV LTR can be dissected.
Leader sequence. The untranslated region between the
primer binding site and the start of gag is likely to contain the
splice donor site for generation of subgenomic (env) tran-
scripts, as well as the packaging signal which specifies incor-
poration of genome RNA into virions. Alignment with JSRV
suggests that the splice donor site is after base 189.
Viral proteins. (i) gag. ENTV gag (nt 256 to 2094) encodes
a 613-amino-acid (aa) polypeptide. The boundaries between
the Gag proteins were assigned, as for JSRV (38), by alignment
with MPMV, squirrel monkey retrovirus (SMRV), and mouse
mammary tumor virus (MMTV) sequences. The ENTV capsid
protein (CA) is encoded by nt 1027 to 1677, and the nucleic
acid binding protein is encoded by nt 1678 to 1995. There are
two sequences of Cys-X2-Cys-X4-His-X4-Cys, separated by 13
residues, in the nucleic acid binding protein. This is typical of
a zinc finger domain and is thought to mediate nucleocapsid
binding to the genomic RNA.
(ii) pro. The pro open reading frame (nt 1878 to 2858)
encodes a 326-residue polypeptide. It is likely to be expressed
FIG. 1. Schematic diagram of the ENTV provirus showing (i) sequence de-
rived from cDNA library clones and (ii) PCR products generated to complete the
sequencing of ENTV.
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FIG. 2. Complete nucleotide sequence of the ENTV genome together with the deduced amino acid sequences of the open reading frames. The limits of U3, R,
and U5 are indicated by arrows. The inverted repeats (IR), primer binding site (PBS), and polypurine tract (PPT) are indicated by underlines. The consensus protease
cleavage site for env SU and TM is indicated by ¹.
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FIG. 2—Continued.
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as a gag-pro fusion polypeptide generated by ribosomal frame-
shifting, as has been shown for MMTV (17). The exact site and
relative efficiency of this frameshifting event remain to be
elucidated. The protein encoded by pro is thought to comprise
two domains, a pseudoprotease (or protease-like) domain
which exhibits a dUTPase activity, as has been suggested for
other retroviruses by both computer analysis (22) and func-
tional studies (9), and an active protease (Pr). The sequence
Leu-Asp-Thr-Gly, indicative of the core amino acid sequence
of cellular aspartyl protease, is encoded by nt 2469 to 2480.
(iii) pol. The pol open reading frame (nt 2825 to 5437)
encodes a peptide of 870 aa giving a predicted molecular mass
of 99 kDa. pol is likely to be translated as a fused gag-pro-pol
polypeptide, again generated by ribosomal frameshifting. pol
encodes the RT and integrase domains. The putative RT active
site is the Tyr-Met-Asp-Asp sequence encoded by nt 3401 to
3412 in ENTV.
(iv) env. The env open reading frame (nt 5346 to 7196), at its
start, overlaps pol, and the env transcript is likely to be gener-
ated by splicing. Like JSRV, ENTV contains two possible ATG
start codons 7 aa apart, but the second is thought to be the
initiation codon used since it is preceded by a predicted splice
acceptor sequence. Retroviral env open reading frames encode
a polypeptide precursor which is cleaved twice, first following
the peptide signal sequence and second following an internal
proteolytic cleavage site, which generates the surface (SU) and
transmembrane (TM) envelope proteins. In ENTV, env en-
codes a polypeptide precursor of 617 aa (predicted molecular
mass, 68 kDa). A hydrophobic region (encoded by nt 5526 to
5573) is thought to be the peptide signal sequence, and cleav-
FIG. 3. Genetic organization of ENTV. Stop codons in the three reading frames are represented by long vertical bars; methionine residues are represented by short
vertical bars.
FIG. 2—Continued.
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age probably occurs cotranslationally at the carboxyl-terminal
end of this sequence. A consensus proteolytic cleavage site
RPKR (encoded by nt 6468 to 6479) generates a SU protein of
302 aa and a TM protein of 239 aa. A 21-aa hydrophobic
region (encoded by nt 6994 to 7046) is likely to be the trans-
membrane domain that anchors the TM protein in the mem-
brane. This gives a predicted cytoplasmic domain of 50 aa and
an extracellular domain of 182 aa.
The predicted molecular mass of the env proteins from the
sequence data alone are 34 kDa for SU and 27 kDa for TM.
However, the actual molecular masses will be larger due to
glycosylation. The motif Asn-X-Ser/Thr, which can serve as a
site for N-linked glycosylation, is found nine times in SU and
twice in TM.
Comparison with JSRV. As shown in Table 1, the genes of
ENTV and JSRV are very similar, with an overall amino acid
similarity of greater than 95%. The biggest differences occur at
the 39 end of env and in the U3 LTR region. In addition, the
open reading frame ORFX postulated for JSRV contains two
stop codons in ENTV and therefore does not appear to be an
open reading frame in ENTV.
The 39 end of env is the most divergent of the coding regions
of JSRV and ENTV. The viruses are 96% identical in SU and
93% identical in TM at the amino acid level. The TM protein
can be further subdivided into external, transmembrane, and
intracytoplasmic domains, which exhibit 98, 81, and 75%
amino acid similarity, respectively (86, 80, and 63% nucleotide
identity). Sequencing of six independent PCR-derived clones
and two cDNA clones across this site confirmed that there is
nucleotide sequence divergence and not a frameshift mutation
at the 39 end of env. Many of the amino acid substitutions are
conservative, suggesting that there are some functional re-
straints on mutation of this protein.
Alignment of the LTR of ENTV with that of JSRV shows
that they are quite similar (75.7% similarity), although JSRV
has an insertion of 21 bp in U3 compared to ENTV. Several
regions contain a cluster of base differences. These regions are
also the most divergent from SERV sequences and for this
reason were chosen for PCR primers. Interestingly, ENTV
does not appear to contain the same regulatory sequences as
JSRV. For example, the NF-1 site (TGGCA4GCCA) seen in
JSRV (38) (Fig. 4, bases 44 to 55) is interrupted by the inser-
tion of a T in ENTV (TGGCA4TGCCA). Also, the 19-bp
tandem repeat identified in JSRV (38) is shorter in ENTV (15
bp). Finally, the C/EBP sequence (Fig. 4, bases 211 to 218) is
not found in ENTV.
Comparison with other retroviruses. Construction of a phy-
logenetic tree based on comparison of gag genes of a range of
different retroviruses (Fig. 5A) shows that ENTV and JSRV
group most closely with MPMV. However, if env sequences are
compared (Fig. 5B), ENTV and JSRV are most similar to
MMTV. (The tree shown is for SU, but comparison of env TM
regions generates a very similar tree.) These results confirm
that ENTV has a type B envelope and a type D capsid.
Construction of a phylogenetic tree based on LTR se-
quences (data not shown) shows that ENTV is most closely
related to JSRV and SERVs. These have only approximately
43% identity to the type D retroviruses examined (simian
SRV-1 type D retrovirus [SRV-1] and MPMV) and less than
33% identity to any of the other retroviruses listed in Fig. 5.
Although this degree of identity is in the same range as that for
comparison between the gag and env genes compared above,
the LTR sequences from diverse retroviruses do not generate
a reliable alignment and do not aid the identification of func-
tional regions of the LTR.
DISCUSSION
This is the first report of the full sequence of ENTV. De-
termination of the sequence has enabled comparisons to be
made between ENTV and other viruses. This confirms that
ENTV is a chimeric typeB/D retrovirus and that it is distinct
from the related virus JSRV and from the endogenous retro-
viral sequences found in the sheep genome. Work currently
under way suggests that ovine ENTV is also distinct from
caprine ENTV (25a). It is hoped that similarities and differ-
ences between members of this family of viruses may give an
insight into the mechanism of cellular transformation and fac-
tors determining cellular tropism.
Although ENTV and JSRV are distinct viruses associated
FIG. 4. Alignment of the LTR sequences of ENTV and JSRV. The JSRV sequence shown is that of York et al. (38). Sequences of the LTR primers are underlined.
Gaps in alignment are shown by dashes; dots represents identity.
TABLE 1. Percentage nucleotide identity and amino acid identity
and similarity between ENTV and JSRV.





gag 89.7 96.7 95.0
pro 95.2 97.2 96.3
pol 92.3 98.0 96.9
env 85.5 95.2 89.0
SU 87.9 96.3 93.4
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with discrete pathologic findings, translation and alignment of
the open reading frames suggests a very high degree of homol-
ogy between them (Table 1). The similarity between the coding
regions of these viruses is in agreement with the evidence that
antisera against CA proteins of ENTV and JSRV are cross-
reactive. Antisera against other proteins have not been tested,
but the degree of sequence similarity between JSRV and
ENTV genes suggests that the proteins will all be antigenically
cross-reactive.
Results for the few regions of SERVs that have been se-
quenced suggest that there is also a high degree of similarity
between any putative expressed endogenous sequences and
ENTV or JSRV. Although these JSRV and ENTV related
endogenous sequences have not been linked to any pathologic
findings, they may play an important role in allowing these
viruses to persist in the host and eventually induce tumours. By
reverse transcription-PCR, SERV transcripts have been de-
tected in all sheep tissues tested, but protein has not been
detected, probably due to the limited sensitivity of detection
methods for proteins compared to nucleic acids. If these SERV
sequences are expressed during ontogeny, it is likely that sheep
would become immunotolerant to them and therefore to the
related exogenous viral proteins, as has been hypothesized
previously (25, 38). The surprisingly small number of sequence
variations observed in our clones from the population of
ENTVs in a single case of ENT supports the hypothesis that
this virus is not subject to immune pressure. The earlier se-
quence data from two regions of ENTV gag (3, 29) also con-
tains few changes from the ENTV sequence presented in this
paper.
A putative open reading frame named ORFX was described
in JSRV (29), and it has been suggested that this may encode
an oncogenic product. In ENTV, the region homologous to
ORFX contains two stop codons and therefore is not an open
reading frame. Since it is likely that these two viruses have the
same oncogenic mechanism, we therefore argue against ORFX
playing any role in cellular transformation.
Apart from ORFX, the main differences between ENTV
and JSRV occur in the LTR and the env TM subunit, suggest-
ing that one or both of these regions must be important in
determining viral tropism. The role of the cytoplasmic domain
of env is thought to be important in envelope processing (21)
and in ensuring the incorporation of the envelope glycopro-
teins into the budding virus (8, 12). It is the SU region of the
retroviral envelope that interacts with the cell surface receptor
and therefore is largely responsible for directing cell tropism at
the surface binding level. Therefore, it is surprising to find that
it is the TM and intracytoplasmic domains of env which differ
the most between these two viruses. The change in the 39 end
of env could be of little significance compared to that of U3
and may be a by-product of a single recombinational event in
the 39 end of the ancestral type B/D retrovirus, which led to the
divergence of JSRV and ENTV. However, it has been shown
that alterations in the TM cytoplasmic domain can alter the
pathogenicity of retroviruses (20, 39), and so a role for this
domain in affecting the pathogenicity of ENTV and JSRV
cannot be ruled out.
While a number of transcription factor binding sites are
identifiable in JSRV, they could not be shown in the ENTV
LTR. The differences in the LTRs of these two viruses are
likely to affect the replication potential and therefore the
pathogenicity of these viruses and may reflect the presence of
different transcription factors in the cells that they infect. Se-
quences in the LTR that regulate transcription in specific cell
types may also contribute to the ability of the retrovirus to
transform these same cell types, as has been shown for murine
leukemia virus (34). Thus, an understanding of transcriptional
control of ENTV may also contribute to elucidating the mech-
anism of viral oncogenesis. We are currently characterizing the
LTR function of these viruses.
In conclusion, we have presented, for the first time, the
complete sequence of ENTV. Analysis of the sequence places
this virus as another member of a group of B/D-type retrovi-
ruses, which also includes JSRV and SERVs. The disease pa-
thology associated with ENTV has some similarities to that
associated with JSRV in that both are tumors derived from
FIG. 5. Phylogenetic trees of (A) gag and (B) env SU nucleotide sequences of ENTV, baboon endogenous retrovirus (BaERV) (18), bovine immunodeficiency virus
(BIV) (11), equine infectious anemia virus (EIAV) (19), JSRV (38), MMTV (24), simian SRV-1 type D retrovirus (SRV-1) (27), MPMV (33), maedi-visna virus (MVV)
(28), and Moloney murine leukemia virus (MoMLV) (32). The sequences were aligned by using GCG Eclustalw, and unrooted trees were constructed by the
neighbor-joining method of Saitou and Nei (30) (Clustree). Horizontal branch lengths are proportional to evolutionary distances as estimated by percent divergence.
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secretory epithelial cells. However, the diseases are clearly
independent and affect different target organs. A virus species
is defined as “a polythetic class of viruses that constitutes a
replicating lineage and occupies a particular ecological niche”
(International Committee on the Taxonomy of Viruses). Thus,
it can be argued that JSRV and ENTV are distinct viral spe-
cies.
The main sequence differences between JSRV and ENTV
reside in ORFX, the U3 LTR, and the 39 end of env. Whether
it is these differences and/or more subtle sequence differences
that direct the tropism of these viruses requires further inves-
tigation.
The availability of the sequence of ENTV is a significant step
that opens the way for the development of ENTV-specific
detection techniques, which are vital to the further study of the
distribution and pathogenesis of this virus and to the develop-
ment of strategies to eradicate ENT.
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